Loading...
XJPX7447
Market cap403mUSD
Jan 17, Last price  
2,017.00JPY
1D
0.85%
1Q
-12.83%
Jan 2017
-20.93%
Name

Nagaileben Co Ltd

Chart & Performance

D1W1MN
XJPX:7447 chart
P/E
22.33
P/S
3.84
EPS
90.32
Div Yield, %
2.97%
Shrs. gr., 5y
-0.89%
Rev. gr., 5y
-0.45%
Revenues
16.41b
-4.48%
14,329,355,00014,340,873,00014,221,827,00013,632,939,00013,669,591,00014,076,158,00014,578,251,00015,175,301,00015,625,092,00016,214,170,00016,150,534,00016,537,600,00017,017,288,00017,144,788,00016,785,667,00017,066,476,00017,563,397,00017,745,488,00017,181,958,00016,412,661,000
Net income
2.82b
-12.53%
2,146,873,0002,272,132,0002,305,612,0002,094,257,0001,516,269,0002,344,384,0002,493,825,0002,371,947,0003,119,278,0003,224,020,0003,225,962,0003,262,039,0003,673,338,0003,675,995,0003,445,153,0003,474,081,0003,647,873,0003,778,265,0003,226,360,0002,822,054,000
CFO
2.29b
+26.15%
2,699,572,0001,911,402,0002,349,227,0001,807,791,0002,518,938,0002,840,915,0003,050,799,0002,919,158,0002,736,778,0003,271,079,0002,727,887,0003,565,352,0003,979,490,0004,009,674,0003,433,275,0003,634,632,0004,448,944,0003,442,608,0001,812,783,0002,286,800,000
Dividend
Aug 29, 202460 JPY/sh

Profile

Nagaileben Co., Ltd. produces and sells medical clothing in Japan. It offers hospital, clinic, and operation room wear products. The company was founded in 1915 and is headquartered in Tokyo, Japan.
URL
https://www.nagaileben.co.jp/
IPO date
Aug 10, 2001
Employees
524
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑082023‑082022‑082021‑082020‑082019‑082018‑082017‑082016‑082015‑08
Income
Revenues
16,412,661
-4.48%
17,181,958
-3.18%
17,745,488
1.04%
Cost of revenue
12,153,842
10,558,091
10,707,419
Unusual Expense (Income)
NOPBT
4,258,819
6,623,867
7,038,069
NOPBT Margin
25.95%
38.55%
39.66%
Operating Taxes
1,252,233
1,445,366
1,689,948
Tax Rate
29.40%
21.82%
24.01%
NOPAT
3,006,586
5,178,501
5,348,121
Net income
2,822,054
-12.53%
3,226,360
-14.61%
3,778,265
3.57%
Dividends
(1,925,721)
(1,935,395)
(1,971,193)
Dividend yield
2.48%
2.72%
3.09%
Proceeds from repurchase of equity
(1,453,375)
(373,468)
(1,231,507)
BB yield
1.87%
0.52%
1.93%
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
923,547
909,861
993,861
Net debt
(26,349,000)
(27,342,080)
(28,734,551)
Cash flow
Cash from operating activities
2,286,800
1,812,783
3,442,608
CAPEX
(168,297)
(284,430)
(115,559)
Cash from investing activities
(1,769,280)
3,417,847
(471,431)
Cash from financing activities
(2,929,744)
(2,935,464)
(3,202,701)
FCF
(2,075,909)
7,044,530
5,268,036
Balance
Cash
26,349,000
27,159,008
28,560,650
Long term investments
183,072
173,901
Excess cash
25,528,367
26,482,982
27,847,277
Stockholders' equity
46,712,499
45,798,211
44,483,635
Invested Capital
18,092,660
17,641,004
14,346,313
ROIC
16.83%
32.38%
37.67%
ROCE
9.76%
15.00%
16.66%
EV
Common stock shares outstanding
31,792
32,251
32,636
Price
2,441.00
10.55%
2,208.00
13.00%
1,954.00
-23.49%
Market cap
77,603,232
8.98%
71,210,884
11.67%
63,770,773
-24.02%
EV
51,254,232
43,868,804
35,036,222
EBITDA
4,525,076
6,896,511
7,321,131
EV/EBITDA
11.33
6.36
4.79
Interest
2,401
Interest/NOPBT
0.03%